| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| USRE39820 | BOEHRINGER INGELHEIM | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
Jan, 2018
(6 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7246615 | BOEHRINGER INGELHEIM | Atomising nozzle and filter and spray generating device |
May, 2016
(7 years ago) | |
| US6176242 | BOEHRINGER INGELHEIM | Method of treating manic depression by brain infusion |
May, 2016
(7 years ago) | |
| US6176442 | BOEHRINGER INGELHEIM | Device for mounting a component exposed to a pressurized fluid |
May, 2016
(7 years ago) | |
| US5964416 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
| US7104470 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
| US6726124 | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Oct, 2016
(7 years ago) | |
|
US6176442 (Pediatric) | BOEHRINGER INGELHEIM | Device for mounting a component exposed to a pressurized fluid |
Dec, 2016
(7 years ago) | |
|
US7246615 (Pediatric) | BOEHRINGER INGELHEIM | Atomising nozzle and filter and spray generating device |
Dec, 2016
(7 years ago) | |
| US6453795 | BOEHRINGER INGELHEIM | Locking mechanism for a spring-actuated device |
Dec, 2016
(7 years ago) | |
| US6149054 | BOEHRINGER INGELHEIM | Mechanical counter for a metering apparatus |
Dec, 2016
(7 years ago) | |
|
US7104470 (Pediatric) | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Apr, 2017
(7 years ago) | |
|
US5964416 (Pediatric) | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Apr, 2017
(7 years ago) | |
|
US6726124 (Pediatric) | BOEHRINGER INGELHEIM | Device for producing high pressure in a fluid in miniature |
Apr, 2017
(7 years ago) | |
|
US6453795 (Pediatric) | BOEHRINGER INGELHEIM | Locking mechanism for a spring-actuated device |
Jun, 2017
(6 years ago) | |
|
US6149054 (Pediatric) | BOEHRINGER INGELHEIM | Mechanical counter for a metering apparatus |
Jun, 2017
(6 years ago) | |
|
USRE39820 (Pediatric) | BOEHRINGER INGELHEIM | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
Jul, 2018
(5 years ago) | |
| US6977042 | BOEHRINGER INGELHEIM | Microstructured filter |
Aug, 2018
(5 years ago) | |
| US6846413 | BOEHRINGER INGELHEIM | Microstructured filter |
Aug, 2018
(5 years ago) | |
| US7802568 | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Feb, 2019
(5 years ago) | |
|
US6846413 (Pediatric) | BOEHRINGER INGELHEIM | Microstructured filter |
Feb, 2019
(5 years ago) | |
|
US6977042 (Pediatric) | BOEHRINGER INGELHEIM | Microstructured filter |
Feb, 2019
(5 years ago) | |
|
US7802568 (Pediatric) | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Aug, 2019
(4 years ago) | |
| US6988496 | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Feb, 2020
(4 years ago) | |
|
US6988496 (Pediatric) | BOEHRINGER INGELHEIM | Cartridge for a liquid |
Aug, 2020
(3 years ago) | |
| US7988001 | BOEHRINGER INGELHEIM | Container provided with a pressure equalization opening |
Aug, 2021
(2 years ago) | |
|
US7988001 (Pediatric) | BOEHRINGER INGELHEIM | Container provided with a pressure equalization opening |
Feb, 2022
(2 years ago) | |
| US7284474 | BOEHRINGER INGELHEIM | Piston-pumping system having o-ring seal properties |
Aug, 2024
(4 months from now) | |
|
US7284474 (Pediatric) | BOEHRINGER INGELHEIM | Piston-pumping system having o-ring seal properties |
Feb, 2025
(10 months from now) | |
| US7896264 | BOEHRINGER INGELHEIM | Microstructured high pressure nozzle with built-in filter function |
May, 2025
(1 year, 30 days from now) | |
|
US7896264 (Pediatric) | BOEHRINGER INGELHEIM | Microstructured high pressure nozzle with built-in filter function |
Nov, 2025
(1 year, 7 months from now) | |
| US7396341 | BOEHRINGER INGELHEIM | Blocking device for a locking stressing mechanism having a spring-actuated output drive device |
Oct, 2026
(2 years from now) | |
| US9027967 | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Mar, 2027
(2 years from now) | |
|
US7396341 (Pediatric) | BOEHRINGER INGELHEIM | Blocking device for a locking stressing mechanism having a spring-actuated output drive device |
Apr, 2027
(2 years from now) | |
|
US9027967 (Pediatric) | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Oct, 2027
(3 years from now) | |
| US7837235 | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Mar, 2028
(3 years from now) | |
|
US7837235 (Pediatric) | BOEHRINGER INGELHEIM | Device for clamping a fluidic component |
Sep, 2028
(4 years from now) | |
| US8733341 | BOEHRINGER INGELHEIM | Atomizer and method of atomizing fluid with a nozzle rinsing mechanism |
Oct, 2030
(6 years from now) | |
|
US8733341 (Pediatric) | BOEHRINGER INGELHEIM | Atomizer and method of atomizing fluid with a nozzle rinsing mechanism |
Apr, 2031
(6 years from now) | |
Spiriva Respimat is owned by Boehringer Ingelheim.
Spiriva Respimat contains Tiotropium Bromide.
Spiriva Respimat has a total of 39 drug patents out of which 27 drug patents have expired.
Expired drug patents of Spiriva Respimat are:
- US7246615
- US6176242
- US6176442
- US5964416
- US7104470
- US6726124
- US6176442*PED
- US7246615*PED
- US6453795
- US6149054
- US7104470*PED
- US5964416*PED
- US6726124*PED
- US6453795*PED
- US6149054*PED
- USRE39820*PED
- US6977042
- US6846413
- US7802568
- US6846413*PED
- US6977042*PED
- US7802568*PED
- US6988496
- US6988496*PED
- US7988001
- US7988001*PED
- USRE39820
Spiriva Respimat was authorised for market use on 15 September, 2015.
Spiriva Respimat is available in spray, metered;inhalation dosage forms.
Spiriva Respimat can be used as maintenance treatment of bronchospasm associated with copd, including chronic bronchitis and emphysema, and reduction of exacerbations in copd patients..
The generics of Spiriva Respimat are possible to be released after 16 April, 2031.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Sep 24, 2017 |
| New Patient Population(NPP) | Feb 15, 2020 |
| Pediatric Exclusivity(PED) | Aug 15, 2020 |
Drugs and Companies using TIOTROPIUM BROMIDE ingredient
Market Authorisation Date: 15 September, 2015
Treatment: Maintenance treatment of bronchospasm associated with copd, including chronic bronchitis and emphysema, and reduction of exacerbations in copd patients.
Dosage: SPRAY, METERED;INHALATION
SPIRIVA RESPIMAT family patents
